Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer have?
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer has 640 citations in the OpenAlex counts ScholarIQ stores.
When was Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer published?
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer has 2016 year in the ScholarIQ index.
What is the open-access status of Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer?
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer?
The DOI for Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer is on the source record.
What is the PMID of Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer?
The PMID for Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer is on the source record.
What is the OpenAlex record for Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer?
The OpenAlex for Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer is on the source record.